The reference no. 30 has been incorrectly published in the original publication. The complete correct reference should read as follows. Mazziotti G, Pedersini R, Vena W, Cosentini D, Carrone F, Pigni S, Simoncini EL, Torrisi R, Zambelli A, Farina D, Balzarini L, Lania AG, Berruti A (2022) Real-world effectiveness of denosumab and bisphosphonates on risk of vertebral fractures in women with breast cancer undergoing treatment with aromatase inhibitors. Calcif Tissue Int 111(5):466–474. https://doi.org/10.1007/s00223-022-01011-w The original article has been corrected.
Antonini, S., Pedersini, R., Birtolo, M., Baruch, N., Carrone, F., Jaafar, S., et al. (2024). Correction to: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors (Journal of Endocrinological Investigation, (2023), 47, 2, (433-442), 10.1007/s40618-023-02174-5) [Altro] [10.1007/s40618-023-02208-y].
Correction to: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors (Journal of Endocrinological Investigation, (2023), 47, 2, (433-442), 10.1007/s40618-023-02174-5)
Zambelli A.;
2024
Abstract
The reference no. 30 has been incorrectly published in the original publication. The complete correct reference should read as follows. Mazziotti G, Pedersini R, Vena W, Cosentini D, Carrone F, Pigni S, Simoncini EL, Torrisi R, Zambelli A, Farina D, Balzarini L, Lania AG, Berruti A (2022) Real-world effectiveness of denosumab and bisphosphonates on risk of vertebral fractures in women with breast cancer undergoing treatment with aromatase inhibitors. Calcif Tissue Int 111(5):466–474. https://doi.org/10.1007/s00223-022-01011-w The original article has been corrected.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
